20/06/2024 Healthcare
Clavsat 1.2, an Amoxicillin Potassium Clavulanate Injection, combines the antibiotic properties of amoxicillin with the beta-lactamase inhibitor clavulanate. This formulation is effective against a broad spectrum of bacterial infections, including those resistant to amoxicillin alone. Administered intravenously, Clavsat 1.2 ensures rapid absorption and distribution in treating severe infections. It is a critical tool in combating bacterial resistance and providing reliable therapy in hospital settings where intravenous administration is necessary.Available in PCD Franchise for injectable range and third party manufacturing.
Clavsat 1.2, an Amoxicillin Potassium Clavulanate Injection, combines the antibiotic properties of amoxicillin with the beta-lactamase inhibitor clavu...
CLAVSAT-375 tablets combine Amoxicillin and Potassium Clavulanate, offering a potent antibiotic therapy. Amoxicillin, a penicillin derivative, inhibit...
Amoxicillin Potassium Clavulanate Oral Suspension IP, known as Clavsat-DS-DUO Dry Syrup, combines amoxicillin, a penicillin antibiotic, with potassium...
Amoxicillin & Potassium Clavulanate Oral Suspension IP, branded as Clavsat DRY SYRUP, is a combination antibiotic used to treat various bacterial ...
More Details